Author: Dorron Blumberg

Jupiter Medical Center Implements Revolutionary Watson for Oncology to Help Oncologists Make Data-Driven Cancer Treatment Decisions

 IBM (NYSE: IBM) and Jupiter Medical Center today announced that Jupiter Medical Center will adopt Watson for Oncology trained by Memorial Sloan Kettering, a cognitive computing platform to provide insights to physicians to help them deliver personalized, evidence-based cancer treatment. Jupiter is the first U.S. community hospital to adopt Watson for Oncology, which will go live at the facility in the beginning of March.

In the U.S., there will be an estimated 1.7M new cancer cases this year, with 125,000 in Florida alone(1). As healthcare providers and systems seek to enable data-driven, evidence-based cancer care, an explosion of medical information has created both challenges and opportunities to improve quality care. Currently, approximately 50,000 oncology research papers are published annually,(2) and by 2020 medical information is projected to double every 73 days(3), outpacing the ability of humans to keep up with the proliferation of medical knowledge. 

Read More

IRMC Welcomes Medical Oncologist Patrick Judson, M.D. to the Scully-Welsh Cancer Cente

Indian River Medical Center (IRMC) welcomes board-certified Medical Oncologist Patrick Judson, M.D., to its multi-specialty group of physicians.
Dr. Judson received his baccalaureate and medical degrees from George Washington University in Washington, DC. He completed his internship and residency in Internal Medicine at Tripler Army Medical Center in Honolulu, Hawaii and served a fellowship in Hematology and Medical Oncology at Walter Reed Army Medical Center in Bethesda, MD. He is board certified in Internal Medicine, Medical Oncology, Hematology and Hospice and Palliative Medicine from the American Board of Internal Medicine.

Read More

New CCSA Report Reveals Canadian Youth Perceptions on Marijuana

The Canadian Centre on Substance Abuse (CCSA) today released Canadian Youth Perceptions on Cannabis, a new study that offers a detailed look at the youth perspective on marijuana. 

Against the backdrop of changes to the legal framework for marijuana, Canadian rates for marijuana use by young people remain among the highest in the world. To contribute to a better understanding of the issue, CCSA held focus groups with Canadians between the ages of 14 and 19. 
Building on our 2013 report on the same subject, we developed Canadian Youth Perceptions on Cannabis to gain a more intimate understanding of the kinds of conversations that are taking place about marijuana every day in schools, at home and in the community. Youth views on marijuana, where they get their information and how they understand that information were all key questions that drove the research and laid the foundation for the key findings of this report. 

Read More

Annual Orthopedic Symposium

Holy Cross Orthopedic Institute in collaboration with Massachusetts General Hospital presents the Annual Orthopedic Symposium February 2-3 at Riverside Hotel, Fort Lauderdale. As techniques, materials and treatment modalities in...

Read More